DOI10.3109/07853890.2014.941919LanguageEnglishTopic Tuberculosis Research and Epidemiology
KeywordsMedicine, Tuberculosis, Tumor necrosis factor alpha, Concomitant, Risk factor, Immunology, Randomized controlled trial, Tumor necrosis factor α, Adalimumab, Internal medicine, PathologyPublishedAugust 8, 2014Citations117 citationsFWCI5.08